PROMETHEUS BIOSCIENCES INC (RXDX) Stock Earnings & Estimates
NASDAQ:RXDX - US74349U1088 - Common Stock
199.92 USD
+0.18 (+0.09%)
199.95 USD
+0.03 (+0.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.23M 9.82% | 3.129M 154.39% | 6.809M 117.61% | 2.094M -69.25% | 1.88M -10.22% | 90.343M 4,705.48% | 263.3M 191.44% | 616.43M 134.12% | 1.291B 109.43% | 1.963B 52.05% | 2.802B 42.74% | |
| EBITDA YoY % growth | -28.9M -81.42% | -87.545M -202.92% | -145.149M -65.80% | -202.449M -39.48% | -237.917M -17.52% | -279.194M -17.35% | -277.914M 0.46% | 224.54M 180.79% | 872.13M 288.41% | 1.942B 122.67% | 2.719B 40.01% | |
| EBIT YoY % growth | -29.01M -81.65% | -87.803M -202.66% | -145.778M -66.03% | -206.223M -41.46% | -253.212M -22.79% | -303.04M -19.68% | -337.811M -11.47% | 125.57M 137.17% | 783.23M 523.74% | 1.48B 88.96% | 2.145B 44.93% | |
| Operating Margin | -2,358.54% | -2,806.10% | -2,140.96% | -9,848.27% | -13,468.74% | -335.43% | -128.30% | 20.37% | 60.67% | 75.39% | 76.55% | |
| EPS YoY % growth | N/A | -3.63 | -3.48 4.13% | -4.07 -16.90% | -4.66 -14.42% | -5.40 -15.99% | -5.98 -10.70% | 2.57 143.00% | 10.60 312.40% | 16.30 53.76% | 22.46 37.78% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.95 -10.54% | -1.00 -11.52% | -1.12 -24.89% | -0.91 -5.56% | -0.93 2.36% | -0.95 5.49% | -0.97 13.79% |
| Revenue Q2Q % growth | 616.08K -51.45% | 657.135K -32.11% | 659.94K 1.06% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -48.034M -42.45% | -51.809M -36.46% | -70.182M -72.43% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -48.365M -42.38% | -51.01M -32.90% | -56.777M -37.37% | -51.878M -6.52% | -53.059M -9.71% | -54.565M -6.97% | -56.122M 1.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.86 -4.88% | -0.93 | 0.07 | 7.45% |
| Q4 2022 Q2Q % growth | -0.90 -16.88% | -0.94 | 0.04 | 4.21% |
| Q3 2022 Q2Q % growth | -0.90 -28.57% | -0.92 | 0.02 | 2.44% |
| Q2 2022 Q2Q % growth | -0.86 -75.51% | -0.93 | 0.07 | 7.69% |
| Q1 2022 Q2Q % growth | -0.82 50.90% | -0.81 | -0.01 | -1.40% |
| Q4 2021 Q2Q % growth | -0.77 | -0.69 | -0.08 | -11.30% |
| Q3 2021 Q2Q % growth | -0.70 | -0.60 | -0.10 | -17.11% |
| Q2 2021 Q2Q % growth | -0.49 | -0.40 | -0.09 | -23.60% |
| Q1 2021 Q2Q % growth | -1.67 | -0.38 | -1.29 | -341.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 1.105M -71.80% | 517.65K | 587.35K | 113.46% |
| Q4 2022 Q2Q % growth | 653K -37.03% | 590.692K | 62.308K | 10.55% |
| Q3 2022 Q2Q % growth | 968K -3.78% | 654.503K | 313.497K | 47.90% |
| Q2 2022 Q2Q % growth | 1.269M 289.26% | 520.649K | 748.351K | 143.73% |
| Q1 2022 Q2Q % growth | 3.919M 415.66% | 669.293K | 3.25M | 485.54% |
| Q4 2021 Q2Q % growth | 1.037M | 554.584K | 482.416K | 86.99% |
| Q3 2021 Q2Q % growth | 1.006M | 357K | 649K | 181.79% |
| Q2 2021 Q2Q % growth | 326K 82.12% | 153K | 173K | 113.07% |
| Q1 2021 Q2Q % growth | 760K 233.33% | 204K | 556K | 272.55% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.23% | 0% | -4.65% |
| Revenue | 0% | 9.82% | 0% | 0% |